These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32298386)

  • 21. Correction: Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer.
    Wang L; Xiao Y; Ping Y; Li J; Zhao H; Li F; Hu J; Zhang H; Deng Y; Tian J; Li X
    PLoS One; 2019; 14(8):e0221483. PubMed ID: 31415668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    Korkola JE; Collisson EA; Heiser LM; Oates C; Bayani N; Itani S; Esch A; Thompson W; Griffith OL; Wang NJ; Kuo WL; Cooper B; Billig J; Ziyad S; Hung JL; Jakkula L; Feiler H; Lu Y; Mills GB; Spellman PT; Tomlin C; Mukherjee S; Gray JW
    PLoS One; 2017; 12(10):e0186551. PubMed ID: 29020035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction: Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLOS ONE Staff
    PLoS One; 2018; 13(11):e0206720. PubMed ID: 30418979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
    Kanomata N; Matsuura S; Nomura T; Kurebayashi J; Mori T; Kitawaki J; Moriya T
    PLoS One; 2017; 12(8):e0183202. PubMed ID: 28792531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
    Rath M; Li Q; Li H; Lindström S; Miron A; Miron P; Dowton AA; Meyer ME; Larson BG; Pomerantz M; Seo JH; Collins LC; Vardeh H; Brachtel E; Come SE; Borges V; Schapira L; Tamimi RM; Partridge AH; Freedman M; Ruddy KJ
    PLoS One; 2020; 15(3):e0230529. PubMed ID: 32163513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    Giudici F; Petracci E; Nanni O; Bottin C; Pinamonti M; Zanconati F; Scaggiante B
    PLoS One; 2019; 14(12):e0227068. PubMed ID: 31856204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
    PLOS ONE Staff
    PLoS One; 2015; 10(2):e0117740. PubMed ID: 25647507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    Hadjialirezaei S; Picco G; Beatson R; Burchell J; Stokke BT; Sletmoen M
    PLoS One; 2018; 13(1):e0190814. PubMed ID: 29293665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer.
    Wang H; Xu C; Kong X; Li X; Kong X; Wang Y; Ding X; Yang Q
    PLoS One; 2019; 14(3):e0214433. PubMed ID: 30897152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    Jank P; Gehlhaar C; Lederer B; Fontanella C; Schneeweiss A; Karn T; Marmé F; Sinn HP; van Mackelenbergh M; Sinn B; Zahm DM; Ingold-Heppner B; Schem C; Stickeler E; Fasching PA; Nekljudova V; Taube ET; Heppner F; Müller V; Denkert C; Loibl S
    PLoS One; 2021; 16(9):e0257142. PubMed ID: 34469495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
    Loi S; Michiels S; Baselga J; Bartlett JMS; Singhal SK; Sabine VS; Sims AH; Sahmoud T; Michael Dixon J; Piccart MJ; Sotiriou C
    PLoS One; 2019; 14(4):e0216175. PubMed ID: 31013327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    Wulaningsih W; Holmberg L; Abeler-Dörner L; Ng T; Rohrmann S; Van Hemelrijck M
    PLoS One; 2016; 11(8):e0161418. PubMed ID: 27512987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.
    Rob D; Marek J; Dostálová G; Goláň L; Linhart A
    PLoS One; 2017; 12(1):e0170881. PubMed ID: 28107535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    Wanandi SI; Limanto A; Yunita E; Syahrani RA; Louisa M; Wibowo AE; Arumsari S
    PLoS One; 2021; 16(2):e0247694. PubMed ID: 33621270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.
    Chan JCY; Diakos CI; Engel A; Chan DLH; Pavlakis N; Gill A; Clarke SJ
    PLoS One; 2021; 16(8):e0244898. PubMed ID: 34351923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    Fatima I; El-Ayachi I; Taotao L; Angeles Lillo M; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
    PLoS One; 2018; 13(5):e0197796. PubMed ID: 29771986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    Syed BM; Morgan D; Setty T; Green AR; Paish EC; Ellis IO; Cheung KL
    PLoS One; 2018; 13(1):e0191979. PubMed ID: 29370282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.
    PLOS ONE Staff
    PLoS One; 2016; 11(12):e0168429. PubMed ID: 27936215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: 3, 3'5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements.
    Sar P; Peter R; Rath B; Mohapatra AD; Mishra SK
    PLoS One; 2013; 8(6):. PubMed ID: 29294469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Hamy AS; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
    PLoS One; 2016; 11(7):e0159123. PubMed ID: 27388624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.